Inactive Instrument

Ambu A/S Stock Nasdaq Copenhagen

Equities

DK0060591204

Medical Equipment, Supplies & Distribution

Sales 2024 * 5.28B 754M Sales 2025 * 5.98B 854M Capitalization 29.44B 4.2B
Net income 2024 * 398M 56.83M Net income 2025 * 604M 86.25M EV / Sales 2024 * 5.61 x
Net Debt 2024 * 195M 27.84M Net cash position 2025 * 159M 22.73M EV / Sales 2025 * 4.89 x
P/E ratio 2024 *
74.2 x
P/E ratio 2025 *
48.9 x
Employees -
Yield 2024 *
0.31%
Yield 2025 *
0.37%
Free-Float 64.63%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 51 19-12-16
Director of Finance/CFO 40 Dec. 31
Chief Tech/Sci/R&D Officer - 23-07-31
Members of the board TitleAgeSince
Chairman 56 20-12-08
Director/Board Member 64 11-12-31
Director/Board Member 54 14-12-31
More insiders
Ambu A/S is specialized in the design, production and marketing of medical supplies. Net sales break down by family of products as follows: - single-use endoscopes (56.3%); - emergency care and resuscitation devices (22.9%): mechanical ventilation devices (insufflators, laryngeal masks, facial masks and respiratory bags), secretion aspirators, immobilization devices, etc. In addition, the group sells dummies for first aid training centers; - monitoring and diagnostic devices (20.8%): including electrodes used in the fields of cardiology, neurophysiology and first aid. At the end of September 2023, Ambu A/S had four production sites located in China, Malaysia, the United States and Mexico. Net sales are distributed geographically as follows: Denmark (1.2%), Europe (37.8%), the United States (49.5%), North America (1.3%) and other (10.2%).
Calendar
More about the company